Skip to main content
Livermore
Livermore
ZHEN

Cooper/Haims Advisors, LLC

SEC CIK
0001654033
Latest filing
Aug 14, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Cooper/Haims Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
2,828
Value
$711.5K
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Cooper/Haims Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,828$711.5K0.3%+67+2.4%AddedHolders
Q1 20262,761$600.4K0.3%+43+1.6%AddedHolders
Q4 20252,718$620.9K0.3%−216−7.4%ReducedHolders
Q3 20252,934$679.2K0.3%−86−2.8%ReducedHolders
Q2 20253,020$560.5K0.3%+86+2.9%AddedHolders
Q1 20252,934$614.6K0.3%−26−0.9%ReducedHolders
Q4 20242,960$525.9K0.3%00.0%UnchangedHolders
Q3 20242,960$584.4K0.3%00.0%UnchangedHolders
Q2 20242,960$507.6K0.3%−394−11.7%ReducedHolders
Q1 20243,354$610.7K0.4%−12−0.4%ReducedHolders
Q4 20233,366$521.6K0.3%−497−12.9%ReducedHolders
Q3 20233,863$575.7K0.4%−19−0.5%ReducedHolders
Q2 20233,882$523.1K0.4%+23+0.6%AddedHolders
Q1 20233,859$615.0K0.5%−125−3.1%ReducedHolders
Q4 20223,984$644.0K0.5%−281−6.6%ReducedHolders
Q3 20224,265$572.0K0.5%+20.0%AddedHolders
Q2 20224,263$653.0K0.4%+126+3.0%AddedHolders
Q1 20224,137$671.0K0.4%−1,199−22.5%ReducedHolders
Q4 20215,336$722.0K0.4%00.0%UnchangedHolders
Q3 20215,336$576.0K0.3%00.0%UnchangedHolders
Q2 20215,336$601.0K0.4%00.0%UnchangedHolders
Q1 20215,336$577.0K0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.